Naseh Abdollahzade
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Naseh Abdollahzade has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Ainaz Mihanfar
Solid Tumor Research Center, Cellular and Molecular Medicine Institute, Urmia University of Medical Sciences Urmia Iran
1 shared publicationBakhtyar Tartibian
Department of Exercise Physiology, Faculty of Physical Education and Sport Sciences, Allameh Tabataba’i University, Tehran, Iran
1 shared publication- Fakhreddin Yaghoob Nezhad
Technical University of Munich Department of Sport and Health Sciences, Exercise Biology Group Munich Germany
1 shared publication - Maryam Majidinia
Solid Tumor Research Center, Cellular and Molecular Medicine Research Institute, Urmia University of Medical Sciences, Urmia, Iran
1 shared publication Naser Ahmadiasl
Department of Physiology, Tabriz University of Medical Sciences, Tabriz, Iran
1 shared publication- Peyvand Bahramiazar
Department of Physiology, Tabriz University of Medical Sciences, Tabriz, Iran
1 shared publication
Latest Publications
- Open Access
- 15 September 2024
- Published by Maad Rayan Publishing Company in Advanced Pharmaceutical Bulletin
- Vol. 14 (4) , 819-835
The Role of Estrogen in Brain MicroRNAs Regulation
Brain disorders are global health issues and cause mortality and morbidity. Experimental data have shown that the rate of cognitive impairments in the reproductive age is lower in women than men, which refers to the importance of sex hormones in the brain. Estrogen as a sex hormone has a protective effect on the central nervous system (1) diseases and its role is changed by aging. Estrogenic hormonal activity affects brain function through their specific estrogen receptors to promote the expression of target gene changes at the transcriptional level. miRNAs regulate gene expression via inhibiting translational processes and have been estimated to be involved in regulating almost 30% of all protein-coding genes in mammals. Our review highlights the present knowledge about the role of estrogen-sensitive miRNAs and their efficacy in regulating brain functions and disorders.
- 15 September 2024
- Published by Maad Rayan Publishing Company in Advanced Pharmaceutical Bulletin
- Vol. 14 (4) , 819-835
Open AccessThe Role of Estrogen in Brain MicroRNAs Regulation
Brain disorders are global health issues and cause mortality and morbidity. Experimental data have shown that the rate of cognitive impairments in the reproductive age is lower in women than men, which refers to the importance of sex hormones in the brain. Estrogen as a sex hormone has a protective effect on the central nervous system (1) diseases and its role is changed by aging. Estrogenic hormonal activity affects brain function through their specific estrogen receptors to promote the expression of target gene changes at the transcriptional level. miRNAs regulate gene expression via inhibiting translational processes and have been estimated to be involved in regulating almost 30% of all protein-coding genes in mammals. Our review highlights the present knowledge about the role of estrogen-sensitive miRNAs and their efficacy in regulating brain functions and disorders.
- 11 May 2022
- Published by Wiley in Journal of Experimental Zoology Part A: Ecological and Integrative Physiology
- Vol. 337 (9-10) , 1010-1024
Molecular mechanisms underlying ameliorative impact of melatonin against age‐dependent chronic arsenic toxicity in rats' brains
Accumulation of random molecular damage such as oxidative DNA damage and inflammation is extremely found to be involved in the aging process. Due to extreme energy requirements and high lipid levels, the brain is more susceptible to oxidative damage during aging especially under exposure to toxic elements such as arsenic. Therefore, this study was aimed to evaluate the ameliorative effects of melatonin, as a neurohormone, on the arsenic‐induced behavioral abnormalities, and the underlying mechanisms. Forty‐eight rats, as young and old aged groups were exposed to 5.55 g/kg body weight arsenic for 4 weeks and then 10 mg/kg melatonin for 2 weeks. Our results showed that arsenic led to anxiety‐like behavioral abnormalities in rats. Increased oxidative stress‐induced damage to DNA, lipids and proteins, decreased potential of antioxidant defense system, induced apoptosis, elevated inflammation, and alteration in the histology of cortical region of brains are observed in the rats exposed to arsenic. These effects were more prominent in aged rats in comparison to young rats. Melatonin successfully attenuates arsenic induced adverse effects on the brain in both age groups. In conclusion, our study shows that melatonin has significant ameliorative impact on age‐dependent cytotoxicity of arsenic in rats' brains.
- 11 May 2022
- Published by Wiley in Journal of Experimental Zoology Part A: Ecological and Integrative Physiology
- Vol. 337 (9-10) , 1010-1024
Molecular mechanisms underlying ameliorative impact of melatonin against age‐dependent chronic arsenic toxicity in rats' brains
Accumulation of random molecular damage such as oxidative DNA damage and inflammation is extremely found to be involved in the aging process. Due to extreme energy requirements and high lipid levels, the brain is more susceptible to oxidative damage during aging especially under exposure to toxic elements such as arsenic. Therefore, this study was aimed to evaluate the ameliorative effects of melatonin, as a neurohormone, on the arsenic‐induced behavioral abnormalities, and the underlying mechanisms. Forty‐eight rats, as young and old aged groups were exposed to 5.55 g/kg body weight arsenic for 4 weeks and then 10 mg/kg melatonin for 2 weeks. Our results showed that arsenic led to anxiety‐like behavioral abnormalities in rats. Increased oxidative stress‐induced damage to DNA, lipids and proteins, decreased potential of antioxidant defense system, induced apoptosis, elevated inflammation, and alteration in the histology of cortical region of brains are observed in the rats exposed to arsenic. These effects were more prominent in aged rats in comparison to young rats. Melatonin successfully attenuates arsenic induced adverse effects on the brain in both age groups. In conclusion, our study shows that melatonin has significant ameliorative impact on age‐dependent cytotoxicity of arsenic in rats' brains.